Welcome to the BioPharm International® weekly news roundup for the week of Oct. 13, 2025. In this video feature, the editors highlight each week’s industry news in an easy-to-consume, fun format. New roundups will drop every Friday, so be sure to come back each week. And be sure to check the links below for more in-depth coverage of each story.

Biologics, obesity R&D partnerships, and China collaborations are driving pharmaceutical M&A and selective venture capital funding in the third quarter of 2025, according to a new report by J.P. Morgan.

Please click here to read more